PUMA BIOTECHNOLOGY, INC.
Balance Sheet
| Line Item | Jun 2018 | Mar 2018 | Dec 2017 | Sep 2017 | Jun 2017 | Mar 2017 | Dec 2016 | Sep 2016 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $95.9M | $78.6M | $81.7M | $79.7M | $80.8M | $105.1M | $194.5M | $52.5M |
| Accounts Receivable | $21.3M | $16.3M | $9.7M | $3.9M | — | — | — | $1.2M |
| Inventory | $2.5M | $2.7M | $2.0M | $89.0K | — | — | — | — |
| Total Current Assets | $170.1M | $111.2M | $106.4M | $119.6M | $160.8M | $204.6M | $236.5M | $117.4M |
| Property, Plant & Equipment | $4.3M | $4.3M | $4.5M | $4.7M | $4.9M | $5.0M | $5.2M | $5.2M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | $48.4M | — | — | — | — | — |
| Total Assets | $227.6M | $169.6M | $165.5M | $181.9M | $172.8M | $216.6M | $252.8M | $134.0M |
| Liabilities | ||||||||
| Accounts Payable | $22.3M | $23.6M | $27.7M | $17.6M | $24.7M | $24.0M | $20.0M | $20.9M |
| Total Current Liabilities | $63.5M | $58.1M | $58.3M | $97.3M | $47.2M | $43.7M | $37.5M | $37.6M |
| Long-Term Debt | $120.3M | $48.6M | $48.5M | — | — | — | — | — |
| Total Liabilities | $189.3M | $112.2M | $112.2M | $102.7M | $52.7M | $49.2M | $43.0M | $42.9M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-1.16B | $-1.11B | $-1.09B | $-1.02B | $-947.2M | $-869.4M | $-796.5M | $-723.9M |
| Total Stockholders' Equity | $38.3M | $57.5M | $53.3M | $79.2M | $120.1M | $167.4M | $209.8M | $91.1M |